Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, New York, USA.
Department of Medicine, Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, Missouri, USA.
Nat Genet. 2015 May;47(5):479-85. doi: 10.1038/ng.3272. Epub 2015 Apr 6.
Nearly all CpG-dense promoters are occupied by the multidomain chromosomal protein FBXL10. We show here that complete inactivation of the Fbxl10 gene leads to dense de novo methylation only of promoters that are co-occupied by both FBXL10 and Polycomb repressive complexes; this methylation results in pervasive defects in embryonic development and the death of homozygous Fbxl10-mutant embryos at midgestation. Deletion of key components of Polycomb repressive complexes 1 and 2 did not lead to ectopic genomic methylation. These results indicate that FBXL10 protects Polycomb-occupied promoters against ectopic de novo methylation. To our knowledge, FBXL10 is the first reported factor whose loss leads to a gain in genomic DNA methylation.
几乎所有 CpG 密集启动子都被多结构域染色体蛋白 FBXL10 占据。我们在这里表明,Fbxl10 基因的完全失活只会导致同时被 FBXL10 和多梳抑制复合物占据的启动子发生新的密集甲基化;这种甲基化导致胚胎发育普遍缺陷,并导致杂合 Fbxl10 突变胚胎在中期死亡。多梳抑制复合物 1 和 2 的关键成分缺失不会导致异位基因组甲基化。这些结果表明 FBXL10 保护多梳抑制复合物占据的启动子免受异位新甲基化的影响。据我们所知,FBXL10 是第一个报道的其缺失会导致基因组 DNA 甲基化增加的因子。